Answers are grounded in this paper and cite their sources.
Serum IL-6 level may be a useful biomarker for assessing disease activity in patients with psoriasis and for predicting responsiveness of joint symptoms to biologic treatment.
No takes yet. Share an insight, caveat, or question.
Muramatsu et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: